Scientific data pertaining to vitamin D supplementation during lactation are scarce. The daily recommended intake for vitamin D during lactation has been arbitrarily set at 400 IU/d (10 g/d). This recommendation is irrelevant with respect to maintaining the nutritional vitamin D status of mothers and nursing infants, especially among darkly pigmented individuals. Our objective was to examine the effect of high-dose maternal vitamin D 2 supplementation on the nutritional vitamin D status of mothers and nursing infants. Fully lactating women (n ҃ 18) were enrolled at 1 mo after birth to 1 of 2 treatment arms, ie, 1600 IU vitamin D 2 and 400 IU vitamin D 3 (prenatal vitamin) or 3600 IU vitamin D 2 and 400 IU vitamin D 3 , for a 3-mo study period. 
INTRODUCTION
Thirty-five years ago, nutritional rickets was thought to be disappearing (1) . Many reports since then, however, indicated that this is not the case (2) (3) (4) (5) . Most cases reported in the past decade involved darkly pigmented infants who had been breastfed exclusively. Hypovitaminosis D among breast-fed infants also is a severe problem in sunlight-rich environments such as the Middle East (6) . This hypovitaminosis D occurs because sun exposure is extremely limited for both mothers and infants and dietary supplementation at the current daily recommended intake (DRI) of 400 IU/d is inconsequential.
In the past, human milk was thought to be an adequate source of antirachitic activity for neonates and growing infants. Even before the discovery of vitamin D, McCollum et al (7) and Park (8) stated that rickets was attributable to the lack of sunlight and a dietary factor X. They observed that factor X was found in "good breast milk" and cod liver oil and that, although rickets did develop among breast-fed children, it was rarely as severe as that among artificially fed infants. Those investigators did not know that the source of vitamin D in the mother's milk was the mother's exposure to the sun, which cutaneously generated large amounts of vitamin D. Early attempts to quantify the antirachitic potential in human milk were crude and yielded little information.
In the 1980s, the antirachitic activity of human milk was defined with sensitive assays to be 20 -70 IU/L (9, 10). Furthermore, almost all of the activity was attributable to vitamin D and 25-hydroxyvitamin D [25(OH)D]. Those studies also demonstrated that dietary maternal vitamin D supplementation and ultraviolet light exposure increased the vitamin D content of human milk (11, 12) . Specker et al (13) determined that the antirachitic content of human milk was lower among African American than white mothers. If a lactating mother has limited sun exposure and/or limited vitamin D intake (such as occurs with the current 400 IU DRI), then the vitamin D content of her milk is poor, especially if she has darker pigmentation.
Studies among normal adults demonstrated that oral vitamin D intakes of up to 10 000 IU/d for a period of 5 mo are safe, with no evidence of toxicity (14, 15) . We hypothesized that vitamin D intakes up to 10 times the DRI among lactating women not only would elevate maternal nutritional vitamin D status to safe healthy levels but also would supply the nursing infants, through milk transfer, with adequate vitamin D to prevent hypovitaminosis D. The hypothesis was investigated in this study.
METHODS

Subjects
Fully lactating mothers within 1 month after birth were eligible for inclusion in the study if they planned to continue full breastfeeding for the next 3 mo. The subjects were randomly divided into 2 groups. Exclusion criteria included preexisting type 1 or type 2 diabetes mellitus, hypertension, parathyroid disease, and uncontrolled thyroid disease.
Study design
This was a randomized controlled trial of lactating mothers. Each subject served as her own control; the vitamin D status at 1 mo was compared with values at 3 additional time points. Mothers were randomized to 1 of 2 vitamin D supplementation regimens. Groups 1 and 2 received 1600 and 3600 IU/d vitamin D 2 , respectively, in an oral suspension. Both groups received additional multivitamin capsules containing 400 IU vitamin D 3 and were instructed to take them daily. Subjects also were instructed to limit sun exposure (for mother and infant). Furthermore, mothers were instructed to limit formula intake by the infant.
Blood, urine, and milk samples were obtained from the mothers at months 1, 2, 3, and 4 of lactation. Infant blood was collected at months 1 and 4 (beginning and end of the study (12) .
Vitamin D 2 was used as a specific tracking agent for maternal dosing because the contribution of vitamin D 2 from other sources would be unlikely or minimal. By using vitamin D 2 in this study, we could precisely define the increase in and/or transfer of vitamin D compounds from the mother to her infant without confounding factors such as extradietary intake and sun exposure.
Laboratory measurements
Total blood calcium and urinary calcium and creatinine concentrations were determined in the General Clinical Research Center at the Medical University of South Carolina. Circulating and milk concentrations of vitamin D 2 , vitamin D 3 , 25(OH)D 2 , and 25(OH)D 3 were determined with HPLC and radioimmunoassay techniques, as described previously (16 -18) .
Statistical methods
Groups 1 and 2 were compared at entrance into the study, for determination of potential differences with respect to sociodemographic and baseline clinical characteristics. The main variables of interest were maternal and infant 25(OH)D 2 , 25(OH)D 3 , and total circulating 25(OH)D concentrations and milk antirachitic activity with time (in months). Data were analyzed with SAS software (SAS Institute, Cary, NC), with Student's t test, chi-square test, and one-way analysis of variance methods.
RESULTS
A convenience sample of 64 lactating women was enrolled, of whom 29 had stopped breast-feeding by the first visit. Thirty-five women came for the first visit; of those, 18 women (13 white women and 5 African American women), 9 in each group, continued breast-feeding and completed the 3-mo study period.
There were 3 African American women in group 1 (2000 IU/d vitamin D) and 2 in group 2 (4000 IU/d vitamin D). The groups did not differ according to age, ethnicity profile, insurance status, number of pregnancies, pregnancy interval, infant sex, birth weight, or gestational age ( Table 1) .
Dietary intakes of vitamin D up to 10 times the DRI for lactating women for a period of 3 mo resulted in no adverse events associated with vitamin D. Serum calcium concentrations all remained in the normal range, and no observation of hypercalcuria was noted (data not shown). This is not surprising, because circulating vitamin D and 25(OH)D concentrations never exceeded normal levels (Figures 1 and 2 ). There was a significant interaction of vitamin D concentrations with time in both groups. Although subjects in group 1 (who received 1600 IU/d vitamin D 2 and 400 IU/d vitamin D 3 ) did not exhibit increases in circulating concentrations of vitamin D 3 from baseline to 3 mo (from 1.0 Ȁ 0.4 to 1.2 Ȁ 1.2 ng/mL, mean Ȁ SEM; P 0.7), they did exhibit increases in circulating vitamin D 2 concentrations (from 0.5 to 2.2 Ȁ 0.7 ng/mL; P 0.01). In this group, circulating 25(OH)D 3 concentrations actually decreased during this time period (from 27.2 Ȁ 3.2 to 18.7 Ȁ 1.7 ng/mL; P 0.02), whereas circulating 25(OH)D 2 concentrations increased (from 0.4 Ȁ 0.1 to 17.4 Ȁ 1.0 ng/mL; P 0.0001). The total circulating 25(OH)D concentrations in this patient group increased from 27.6 Ȁ 3.3 to 36.1 Ȁ 2.3 ng/mL (P 0.05).
Compared with group 1, higher concentrations of total circulating 25(OH)D were observed for subjects in group 2 (who received 3600 IU/d vitamin D 2 and 400 IU/d vitamin D 3 ). In group 2, circulating vitamin D 3 concentrations increased slightly (from 0.9 Ȁ 0.4 to 2.8 Ȁ 1.0 ng/mL; P 0.06), whereas circulating vitamin D 2 concentrations increased from 0.6 Ȁ 0.1 to 6.6 Ȁ 2.4 ng/mL (P 0.04) ( Figure 2 ). As for group 1, circulating 25(OH)D 3 concentrations decreased (from 32.0 Ȁ 2.5 to 18.9 Ȁ 3.0 ng/mL; P 0.0007), whereas 25(OH)D 2 concentrations increased (from 1.8 Ȁ 1.0 to 25.0 Ȁ 2.5 ng/mL; P 0.0001). Total circulating 25(OH)D concentrations increased from 32.9 Ȁ 2.4 to 44.5 Ȁ 3.9 ng/mL (P 0.04).
Comparisons between groups 1 and 2 revealed no significant differences at baseline for any of the vitamin D indices for mothers and infants. Although 25(OH)D 3 concentrations did not differ between the groups during the study period, there were significant differences between the 2 groups with respect to 25(OH)D 2 concentrations (P 0.01), with higher concentrations in the 4000 IU group.
The changes in milk antirachitic activity observed during the study period are presented in 1 No significant differences were found between the 2 groups with respect to sociodemographic data and maternal/infant clinical factors. the medical profession and the media. We are told to avoid the sun totally or to wear sunscreen. In fact, the American Academy of Pediatrics (19) recommends that newborn infants receive no sun exposure during the first 6 mo of life. By following these recommendations, we disrupt an important endocrine pathway that has evolved over millions of years, ie, the solar-driven production of vitamin D 3 in our skin. This lack of solar exposure is especially acute among darkly pigmented individuals, because they require many times the exposure to generate vitamin D 3 in the epidermis (20) .
The second reason for hypovitaminosis D among breastfed infants is the inadequate DRI value for vitamin D among lactating women. In fact, the DRI of 200 -400 IU/d, which was arbitrarily set, is inadequate for the adult population in general (21) .
The DRI for vitamin D clearly needs to be revised. For example, white individuals exposed (total body) to 10 -15 min of peak sunlight in the summer endogenously produce and release into the circulation ȁ20 000 IU of vitamin D 3 (22, 23) . It is ironic that the 1989 US Nutrition Guidelines state that 2000 IU/d vitamin D may be harmful (24) . This guideline is in error and is based on faulty scientific findings (25) . In fact, other work showed that vitamin D intakes up to 10 000 IU/d produced no ill effects and elevated circulating 25(OH)D concentrations to the upper limits of the normal range (26) .
To our knowledge, no prospective study has been performed to evaluate supplementation with 400 IU/d vitamin D for lactating mothers. In other words, we have no idea what effect the DRI has on the nutritional status of lactating mothers or their nursing infants. However, with the vitamin D intake regression model described by Heaney et al (15) , a 400 IU/d intake would increase maternal circulating 25(OH)D concentrations by only 2.8 ng/mL after 5 mo of supplementation. This underscores how irrelevant a 400 IU/d intake is for adults.
We have been able to identify only 3 prospective studies that examined vitamin D supplementation during lactation (27) (28) (29) . Greer and Marshall (27) found that exclusively breastfed white infants nursed during the winter in a northern climate maintained a "minimally normal" vitamin D status for a period of 6 mo. It should be noted, however, that the circulating 25(OH)D concentrations among the breastfeeding infants declined as the study progressed, as noted in our own study. Supplementation with high-dose vitamin D for mothers resulted in increases in circulating 25(OH)D concentrations that were completely attributable to increased 25(OH)D 2 concentrations (Figures 1 and 2 ). This increase was more pronounced among mothers who received 3600 IU/d vitamin D 2 . A similar profile was observed for circulating vitamin D 2 (Figures 1 and 2) . It is of interest that, in both groups, circulating 25(OH)D 3 concentrations decreased although the mothers were receiving 400 IU/d vitamin D 3 . This observation reinforces the uselessness of a 400 IU DRI for adults. It is important to note that, while the mothers received 4000 IU/d vitamin D for a period of 3 mo, maternal 25(OH)D concentrations were elevated to and remained in a normal healthy range. Again, no adverse side effect was observed.
The initial antirachitic activity in the milk from the mothers in our study was not different from previously reported values (10, 13, 16) What can be inferred from the data in the current study? First, we need to address sun exposure or, rather, the lack of it. Individuals are constantly told not to receive direct sun exposure or to wear sunscreen if they do. By following this advice, we are eliminating the initial step in an important endocrine system that can easily generate 10 000 -20 000 IU/d vitamin D (22, 23) . We conclude that the current DRI of 400 IU/d vitamin D for lactating mothers is irrelevant to the vitamin D nutritional status of mothers and nursing infants. Maternal vitamin D intakes of ͧ 4000 IU/d appear to be safe and to provide sufficient vitamin D to ensure adequate nutritional vitamin D status for both mothers and nursing infants. Additional detailed studies will be required to determine the optimal vitamin D supplementation regimen for lactating women.
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